Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years

DOI Web Site PubMed 被引用文献7件 参考文献66件
  • Ito Yasuhiro
    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan
  • Kihara Minoru
    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan
  • Takamura Yuuki
    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan
  • Kobayashi Kaoru
    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan
  • Miya Akihiro
    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan
  • Hirokawa Mitsuyoshi
    Department of Pathology, Kuma Hospital, Kobe 650-0011, Japan Department of Pathology, Kuma Hospital, Kobe 650-0011, Japan
  • Miyauchi Akira
    Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan

この論文をさがす

説明

Age is an important prognostic factor of papillary thyroid carcinoma (PTC). In this study, we investigated the prognosis and prognostic factors of PTC in patients younger than 20 years. We enrolled 110 patients who underwent initial surgery at Kuma Hospital between 1987 and 2008. Tumor size > 4 cm, metastatic node ≥ 3 cm, and significant extrathyroid extension were more frequently detected in 8 patients with distant metastasis at diagnosis than in 102 patients without distant metastasis. Ten- and 20-year lymph node recurrence-free survival (LN-RFS) and distant recurrence-free survival (DRFS) rates were 84 and 80%, and 95 and 89%, respectively. Metastatic node ≥ 3 cm, age ≤ 16 years, tumor size > 4 cm, and male gender affected LN-RFS, and the former two had an independent prognostic value in multivariate analysis. Metastastic node ≥ 3 cm, significant extrathyroid extension, age ≤ 16 years, tumor size > 4 cm, and a male gender predicted a poor DRFS, and the former two were independent prognostic factors. To date, only 2 patients have died of PTC. These findings suggest that, in the subset of PTC patients younger than 20 years, metastatic node ≥ 3 cm, significant extension, and age ≤ 16 were important signs of aggressiveness of carcinoma, and careful treatment is necessary for patients with these characteristics, although the cause-specific survival was excellent.

収録刊行物

  • Endocrine Journal

    Endocrine Journal 59 (7), 539-545, 2012

    一般社団法人 日本内分泌学会

被引用文献 (7)*注記

もっと見る

参考文献 (66)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ